Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $227.2 million.

  • Tandem Diabetes Care's Short-term Investments fell 4645.72% to $227.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.2 million, marking a year-over-year decrease of 4645.72%. This contributed to the annual value of $369.1 million for FY2024, which is 976.64% down from last year.
  • Tandem Diabetes Care's Short-term Investments amounted to $227.2 million in Q3 2025, which was down 4645.72% from $251.2 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Short-term Investments registered a high of $552.6 million during Q4 2021, and its lowest value of $227.2 million during Q3 2025.
  • Moreover, its 5-year median value for Short-term Investments was $409.0 million (2023), whereas its average is $413.8 million.
  • Per our database at Business Quant, Tandem Diabetes Care's Short-term Investments surged by 35804.04% in 2021 and then plummeted by 4645.72% in 2025.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Short-term Investments stood at $552.6 million in 2021, then fell by 19.59% to $444.4 million in 2022, then fell by 7.95% to $409.0 million in 2023, then dropped by 9.77% to $369.1 million in 2024, then crashed by 38.45% to $227.2 million in 2025.
  • Its Short-term Investments was $227.2 million in Q3 2025, compared to $251.2 million in Q2 2025 and $315.1 million in Q1 2025.